Abstract 4134483: How succesfully can we presribe the 'four pillars' of medications for patients with heart failure with reduced LV systolic function?
Circulation
NOVEMBER 11, 2024
Introduction:European, American and UK guidelines all endorse the prescription of the 'four pillars' of treatment (ACE/ARBs, b-blockers, MRAs and SGLT2 inhibitors) for heart failure with reduced LV systolic function (HFrEF). Circulation, Volume 150, Issue Suppl_1 , Page A4134483-A4134483, November 12, 2024.
Let's personalize your content